08048035968
Erlotero 100 mg Good Quality Tablets to UK - Birmingham | Phoenix Exim | Trusted Exporter

1. General Information

Erlotero 100 mg Tablet is an oral targeted cancer medicine containing erlotinib 100 mg. It is marketed by Hetero Healthcare Pvt. Ltd. and is available as a prescription medicine. Erlotinib is designed to interfere with signals that encourage certain cancer cells to grow and multiply.

It may be prescribed for appropriately selected patients with certain forms of non-small cell lung cancer and pancreatic cancer. The exact indication depends on the patient's diagnosis, molecular characteristics, previous treatment, and oncologist's recommendation.

2. Product Information

  • Brand: Erlotero 100 mg Tablet
  • Active ingredient: Erlotinib
  • Strength: 100 mg
  • Dosage form: Tablet
  • Therapeutic class: Anti-cancer medicine / Tyrosine kinase inhibitor
  • Administration: Oral
  • Prescription status: Prescription medicine
  • Common pack: 30 tablets, depending on market and packaging
  • Primary therapeutic areas: Non-small cell lung cancer and pancreatic cancer

3. Uses of Erlotero 100 mg

Erlotero 100 mg may be prescribed for:

  • Certain types of non-small cell lung cancer (NSCLC)
  • Certain cases of pancreatic cancer
  • EGFR-targeted treatment when clinically appropriate

For NSCLC, erlotinib may be used when the cancer has appropriate molecular characteristics, such as an activating EGFR mutation, according to the treatment strategy selected by the oncologist.

4. Benefits of Erlotero 100 mg

Erlotero provides targeted anti-cancer activity rather than functioning like conventional cytotoxic chemotherapy. By blocking EGFR-related signaling, it can help slow the growth and multiplication of susceptible cancer cells.

The potential benefit depends on factors such as the cancer type, EGFR status, disease stage, previous treatments, and individual response. It should therefore be used only under specialist supervision.

5. Side Effects of Erlotero 100 mg

Possible side effects include:

  • Diarrhea
  • Skin rash
  • Nausea
  • Vomiting
  • Fatigue
  • Abdominal pain
  • Weight loss
  • Cough
  • Breathlessness
  • Muscle or bone pain
  • Mouth inflammation/stomatitis
  • Fever
  • Constipation
  • Changes in liver-function tests

Some adverse reactions can be serious. Patients should contact their healthcare professional promptly if they develop severe or persistent diarrhea, significant breathing difficulty, eye problems, severe skin reactions, or other concerning symptoms.

6. Common Side Effects

Commonly reported effects include rash, diarrhea, nausea, vomiting, fatigue, abdominal discomfort, cough, weight loss, and mouth inflammation.

Many side effects can be managed by the treating medical team, but patients should not stop or change the dose themselves.

7. How to Use Erlotero 100 mg

  • Take Erlotero exactly as prescribed by the oncologist.
  • It is generally taken once daily when prescribed on the standard schedule.
  • Take it on an empty stomach, at least 1 hour before or 2 hours after food.
  • Swallow the tablet whole with water.
  • Do not crush, chew, or break it unless specifically instructed by a healthcare professional.
  • Take it at approximately the same time each day.
  • Do not take extra tablets if a dose is missed without consulting your healthcare professional.

8. How Erlotero 100 mg Works

Erlotero contains erlotinib, which inhibits the activity of the epidermal growth factor receptor (EGFR) tyrosine kinase.

EGFR signaling can promote cancer-cell growth and multiplication. Erlotinib blocks this signaling pathway, which can help slow or inhibit the growth of susceptible cancer cells.

9. Safety Advice

  • Pregnancy: Erlotinib can harm a developing fetus. Effective contraception should be discussed with the treating doctor.
  • Breastfeeding: Breastfeeding may not be safe during treatment; discuss this with your doctor.
  • Liver disease: Tell your doctor about existing liver problems. Liver-function monitoring may be required.
  • Kidney disease: Inform your doctor if you have kidney problems.
  • Sun exposure: Erlotinib can increase skin sensitivity to sunlight; protective clothing and sunscreen may be recommended.
  • Smoking: Smoking can affect erlotinib exposure and treatment effectiveness; patients should discuss smoking with their oncologist.
  • Drug interactions: Tell your doctor about all medicines and supplements you use. Acid-reducing medicines can affect erlotinib absorption, and some drug combinations can cause significant interactions.
  • Prescription use: Do not use Erlotero without a qualified doctor's prescription and supervision.

10. Frequently Asked Questions

Q1. What is Erlotero 100 mg used for?
It is used for certain cases of non-small cell lung cancer and pancreatic cancer.

Q2. What is the active ingredient in Erlotero 100 mg?
The active ingredient is erlotinib 100 mg.

Q3. Is Erlotero a chemotherapy medicine?
Erlotero is a targeted anti-cancer therapy and belongs to the tyrosine kinase inhibitor class rather than conventional cytotoxic chemotherapy.

Q4. Should Erlotero be taken with food?
It is generally taken on an empty stomach—at least one hour before or two hours after food. Follow your doctor's instructions.

Q5. Can Erlotero cause skin rash?
Yes. Skin rash is a commonly reported adverse effect of erlotinib.

Q6. How long should Erlotero be taken?
The duration varies according to the cancer, treatment response, tolerability, and the oncologist's treatment plan.

Q7. Can I replace Erlotero with another medicine?
Do not substitute it yourself. An oncologist should select an alternative based on the active ingredient, strength, cancer type, molecular profile, and treatment plan.

11. Substitute for Erlotero 100 mg

Medicines containing erlotinib 100 mg may be considered alternatives when clinically appropriate. Examples listed by Indian medicine references include:

  • Erlocip 100 Tablet
  • Erlonat 100 mg Tablet
  • Erlons 100 mg Tablet
  • Erlotaz 100 Tablet
  • Tarceva 100 mg Tablet

Availability and suitability vary by country. A substitute should be selected by a qualified healthcare professional and should not be changed without medical approval.

12. SEO Keywords for Phoenix Exim

Primary keywords:

  • Erlotero 100 mg Tablet exporter
  • Erlotero 100 mg supplier India
  • Erlotero 100 mg wholesale supplier
  • Erlotinib 100 mg Tablet exporter
  • Erlotinib 100 mg pharmaceutical supplier
  • Erlotero 100 mg medicine exporter from India
  • Erlotero 100 mg oncology medicine supplier
  • Erlotero 100 mg anti cancer medicine exporter
  • Erlotinib 100 mg exporter from Nagpur
  • Erlotero 100 mg tablets supplier Nagpur

International B2B keywords:

  • Erlotero 100 mg supplier USA
  • Erlotero 100 mg exporter to UK
  • Erlotero 100 mg supplier Australia
  • Erlotero 100 mg supplier Singapore
  • Erlotero 100 mg supplier Canada
  • Erlotero 100 mg supplier South Korea
  • Erlotero 100 mg supplier UAE
  • Erlotinib 100 mg exporter to USA
  • Erlotinib 100 mg exporter to UK
  • Erlotinib 100 mg exporter to Australia
  • Erlotinib 100 mg exporter to Canada
  • Erlotinib 100 mg exporter to UAE
  • Erlotinib 100 mg wholesale pharmaceutical supplier
  • Erlotinib oncology medicine B2B supplier
  • Erlotinib cancer medicine international supplier

Phoenix Exim SEO phrases:

  • Phoenix Exim Erlotero 100 mg supplier
  • Phoenix Exim Erlotinib 100 mg exporter from Nagpur India
  • Phoenix Exim anti cancer medicine exporter India
  • Phoenix Exim oncology medicine supplier
  • trusted Erlotinib 100 mg exporter from India
  • pharmaceutical medicine exporter from Nagpur India
  • prescription oncology medicine exporter India
  • Indian pharmaceutical exporter for international buyers
  • Erlotero 100 mg B2B pharmaceutical supplier
  • Erlotinib 100 mg international pharmaceutical exporter
Aug 14th, 2026 3:25 PM

Keywords